Digital Savvy Pharma Marketer 2020

Download↗Talk to us

Objective of Pharma Marketer Survey Report

Indegene’s latest global survey analysis – “The Digital Savvy Pharma Marketer 2020”- provides insights into the latest channel preferences, technology utilization, and content strategies across different levels of marketing organizations in pharmaceutical companies. Marketers can use the survey results as a tool to:

  • Guide budgeting and brand planning exercise

  • Support strategy formulation around channel selection and content optimization

  • Benchmark/validate marketing mix and digital channel utilization

  • Help drive maximum value by enabling better customer experience through orchestrated customer journeys

Executive Summary

Advancements in technology are redefining marketing practices in the pharmaceutical industry. Traditional channels such as television and radio are unable to provide on-demand information to a new generation of healthcare professionals, who are as comfortable with a stethoscope as they are with a smartphone and are moving the marketing needle.

In line with this vision, pharma organizations, although initially perceived as reluctant adopters, are riding on the wave of digital evolution. They cannot risk standing on the periphery anymore by only providing transactional and point-in-time solutions. Hence, pharma marketers are exploring a multitude of digital initiatives to deliver personalized content through a physician’s preferred channel at a time of their choosing.

Digitalization is yet to fundamentally transform the marketplace; however, digital touchpoints have become an essential pillar for customer engagement. Additionally, the use of images and microcontent by marketers, given the short attention spans of physicians, has seen marketers lean toward the employment of a whole suite of tools and applications for digital engagement.

Indegene’s latest global survey analysis – “The Digital Savvy Pharma Marketer 2020”- confirms the trend of increasing digital spend to keep up with changing industry dynamics. Key insights include:

  • The average allocation toward digital channels from overall marketing budget reached a peak of 34% this year, twice the 2016 allocation figures

  • About 20% respondents foresee an increase in their digital spend by more than 50% over the next 3 years

  • Digital channels deliver 24% higher productivity as compared to traditional channels such as TV/radio to engage patients

  • Key opinion leader webinars, social media, and marketing emails are viewed as the most effective digital channels to engage healthcare professionals

  • Personalization of content has become a key focus area to maximize value for customers.

Respondent Analysis

The findings presented in this survey report are an analysis of aggregate responses of 100+ participants across the Americas, Europe, and Asia and includes marketers from top 100 pharma and bioscience organizations.

Geography Mix; 27%; The Americas; 5%; Africa; 29%; Europe; 39%; Asia
Designation/Function Area; 42%; Marketing Directors; 37%; Marketing Managers; 21%; CXOs

Primary Research

Channel Preferences and Effectiveness

  • Channels preference: Called-on marketing

  • Channel preference: White space marketing

  • Called-on vs white space marketing trends

Channel Preference // Called-on Marketing

Key Takeaways:

With the increase in consumption of digital content among HCPs, it is not surprising to note that social media ranks among the top three channels across all regions for pharma marketers to engage with HCPs.

Lead Channels [Rank I]; Europe; 65.8 Non-promotional websites; 65.6 KOL webinars; 65.3 Social media; Asia; 71.0 KOL webinars; 69.3 Social media; 66.1 Promotional websites; The Americas; 73.1 KOL webinars; 72.7 Social media; 68.1 Emails through reps; Upcoming Channels [Rank II]; Europe; 65.1 Journals; 62.2 E-detailing; 61.2 Remote detailing; Asia; 66.0 Non-promotional websites; 63.4 E-detailing; 62.2 Journals; The Americas; 67.4 Non-promotional websites; 65.7 Mobile apps; 64.6 Promotional websites

At the global level:

  • Top lead channels: Key opinion leader (KOL) webinars and social media

  • Top upcoming channel: Marketing emails

  • Top potential channels: Journals and non-promotional websites

  • Top occasionally used channel: Text messaging

Potential Channels [Rank III]; Europe; 60.7 Marketing emails; 59.8 Mobile apps; 59.1 Emails through reps; Asia; 62.0 Mobile apps; 61.2 Third-party website; 59.5 Marketing emails; The Americas; 64.3 E-detailing; 60.0 Remote detailing; 59.7 Marketing emails; Occasionally Used Channels [Rank IV]; Europe; 56.6 Text messaging; 55.6 Third-party websites; 54.7 Promotional websites; Asia; 57.6 Remote detailing; 56.3 Emails through reps; 49.6 Text messaging; The Americas; 59.4 Third-party websites; 56.0 Journals; 52.6 Text messaging

Region Specific

Europe; 65.8 Non-promotional websites; 65.6 KOL webinars; 65.3 Social media; 65.1 Online journals; 62.2 e-Detailing; 61.2 Remote detailing; 60.7 Marketing emails; 59.8 Mobile apps; 59.1 Emails through reps; 56.6 Text messaging; 55.6 Third-party website; 54.7 Promotional websites; Asia; 71.0 KOL webinars; 69.3 Social media; 66.1 Promotional websites; 66.0 Non-promotional websites; 63.4 e-Detailing; 62.2 Online journals; 62.0 Mobile apps; 61.2 Third-party websites; 59.5 Marketing emails; 57.6 Remote detailing; 56.3 Emails through reps; 49.6 Text messaging; The Americas; 73.1 Non-promotional websites; 72.7 KOL webinars; 68.1 Social media; 67.4 Online journals; 65.7 e-Detailing; 64.6 Remote detailing; 64.3 Marketing emails; 60.0 Mobile apps; 59.7 Emails through reps; 59.4 Text messaging; 56.0 Third-party websites; 52.6 Promotional websites

Channel Preference // White Space Marketing

Key Takeaways:

  • The top four preferred channels to drive awareness and product updates among HCPs in white space areas include key opinion leader (KOL) webinars, social media, marketing emails, and promotional websites. Peer promotion continues to be a critical driver for pharma companies to raise the profiles of their products

  • Marketers continue to use promotional websites rather than native apps to deliver content, confirming with physicians' preference to use laptops or personal computers to access new content (as discovered in another Indegene study – The Digital Savvy HCP Survey 2019)

Lead Channels; Europe; 67.4; 67.2; 62.1; Social media; KOL webinars; Journals; Asia; 70.2; 70.1; 66.5; Social media; KOL webinars; Promotional website; The Americas; 72.0; 69.6; 69.5; Social media; KOL webinar; Marketing emails; Upcoming Channels; Europe; 61.4; 61.2; 57.7; Tele detailing; Promotional website; Marketing emails; Asia; 66.3; 62.8; 62.4; Tele detailing; Third-party website; Marketing emails; The Americas; 68.7; 63.4; 57.8; Third-party website; Mobile apps; Promotional website; Potential Channels; Europe; 55.5; 54.9; 53.8; Third-party website; Text messaging; Mobile apps; Asia; 61.6; 61.3; 51.3; Text messaging; Mobile apps; Journals; The Americas; 57.8; 54.5; 39.1; Text messaging; Tele detailing; Journals

Region Specific

Europe; 67.4 Advertisements; 67.2 Webinars; 62.1 Social media; 61.4 Marketing emails; 61.2 Promotional websites; 57.7 Tele-detailing; 55.5 Mobile apps; 54.9 Text messaging; 53.8 Third-party websites; Asia; 70.2 Promotional websites; 70.2 Webinars; 66.5 Social media; 66.3 Marketing emails; 62.8 Third-party websites; 62.4 Tele-detailing; 61.6 Advertisements; 61.3 Mobile apps; 51.3 Text messaging; The Americas; 72.0 Marketing emails; 69.6 Webinars; 69.6 Social media; 68.7 Promotional websites; 63.4 Mobile apps; 57.8 Third-party websites; 57.8 Advertisements; 54.5 Tele-detailing; 39.1 Text messaging

Called-on vs White Space Marketing Trends

Key Takeaways:

KOL webinars rank among the top 3 channels across all regions in both called-on as well as white space marketing channels. It is the channel of choice for marketers

Top 3 Called-on Marketing Channels; Europe; 65.8 Non-promotional websites; 65.6 KOL webinars; 65.3 Social media; Asia; 71.0 KOL webinars; 69.3 Social media; 66.1 Promotional websites; The Americas; 73.1 KOL webinars; 72.7 Social media; 68.1 Emails through reps; Top 3 White Space Marketing Channels; Europe; 69.5 Journals; 69.6 KOL webinars; 72.0 Social media; Asia; 66.5 Promotional websites; 70.1 KOL webinars; 70.2 Social media; The Americas; 62.1 Marketing emails; 67.2 KOL webinars; 67.4 Social media

Primary Research

Digital Marketing Budget Allocations

  • Current Trends

  • The Americas: Channel Spend and Budget Allocations

  • Asia: Channel Spend and Budget Allocations

  • Europe: Channel Spend and Budget Allocations

Digital Marketing Budget Allocation // Current Trends

Key Takeaways:

On an average, leading pharma organizations spend approximately 34% of total marketing budget on digital channels.

  • Millennial HCP preferences play a key role in influencing the decisions made by marketers as smartphone and tablet usage continues to increase significantly

  • About 20% respondents foresee over 50% increase in their digital spend over the next 3 years

Current Spend Across Digital Channels [By Percentage of Respondents]

Current Spend Across Digital Channels [By Percentage of Respondents]; 42% <30%; 40% 31%-50%; 15% 51%-70%; 3% >70%

Digital Marketing Budget Allocation // The Americas

Channel Spend

Channel Spend; Online journals 4%; Text messaging 6%; Social media 6%; e-Detailing 7%; Non-promotional websites 8%; KOL webinars 9%; Mobile apps 9%; Remote detailing 9%; Medical science liaison 11%; Marketing emails 14%; HCP/Brand portals 19%
Current Budget Allocation [By Percentage of Respondents]; 46% <30%; 29% 31%-50%; 25% 51%-70%; 0% >70%; 3-Year Projection; Projected Budget Allocation [By Percentage of Respondents]; 35% <30%; 26% 31%-50%; 33% 51%-70%; 6% >70%

Digital Marketing Budget Allocation // Europe

Channel Spend

Channel Spend; Text messaging 6%; Non-promotional websites 6%; Remote detailing 6%; Mobile apps 7%; Social media 8%; Online journals 8%; e-Detailing 9%; KOL webinars 11%; Medical science liaison 12%; Marketing emails 13%; HCP/Brand portals 16%
Current Budget Allocation [By Percentage of Respondents]; 35% <30%; 50% 31%-50%; 11% 51%-70%; 4% >70%; 3-Year Projection; Projected Budget Allocation [By Percentage of Respondents]; 27% <30%; 30% 31%-50%; 32% 51%-70%; 11% >70%

Digital Marketing Budget Allocation // Asia

Channel Spend

Channel Spend; Text messaging 6%; Non-promotional websites 6%; Remote detailing 6%; Mobile apps 7%; Social media 8%; Online journals 8%; e-Detailing 9%; KOL webinars 11%; Medical science liaison 12%; Marketing emails 13%; HCP/Brand portals 16%
Current Budget Allocation [By Percentage of Respondents]; 46% <30%; 40% 31%-50%; 11% 51%-70%; 3% >70%; 3-Year Projection; Projected Budget Allocation [By Percentage of Respondents]; 49% <30%; 21% 31%-50%; 21% 51%-70%; 9% >70%

A Typical $100 Spend by Pharma Marketers

Key Takeaways:

On an average, the number of organizations that spend more than 20% of their budget on digital marketing channels is expected to increase by 31% over the next 3 years and by 73% over the next 6 years.

  • The budget increase pattern highlights how marketing organizations across the globe are undergoing a structural change

HCP/Brand Portals | $15.29; Marketing Emails | $14.21; Medical Science Liaison | $8.83; KOL Webinars | $8.77; e-Detailing | $7.86; Budget spent across multiple marketing channels (in $); Text Messages/SMS | $ 12; Non-promotional Websites | $ 7.10; Social Media | $ 7.54; Mobile Apps | $ 7.65; Online Journals | $ 7.62; Remote Detailing | $ 7.64; Non-promotional Spend – 24.7%; Promotional Spend – 75.3%

Primary Research

Engagements Trends – Content Strategies and Technology Adoption

  • Effective Content Strategies

  • Technology Adoption

Effective Content Strategies

Key Takeaways:

At the global level, personalization emerged as the top most effective content strategy for pharma marketers, followed by promotional infographics and repurposing of content into videographics.

Content personalization has generated the maximum returns for pharmaceutical companies as they grapple with reducing face-to-face engagements through their medical representatives.

Top 3 effective content strategies in

  • The Americas: Personalization of content, retargeting of content, and localization of content

  • Europe: Personalization of content, adapting content to device compatibility, and promotion of content through infographics

  • Asia: Personalization of content, repurposing content into videographics, and promotion of content through infographics

Content Strategies Utilized by Percentage of Pharma Marketers

Content Strategies Utilized by Percentage of Pharma Marketers; Localization of content 60%; Retargeting of content 64%; Adapting content to device compatibility 68%; Repurposing content into video graphics 69%; Promotion of content in infographics 70%; Personalization of content 74%

Technology Adoption // Enterprise Capability

Key Takeaways:

Marketing organizations have built up a suite of automation and analytics tools to push content through various digital channels. However, based on survey results, these companies utilize what is now considered as “staple” technology (such as campaign management) and need to scale up investments in advanced technologies.

Digital analytics tools seem to be the most popular technology choice among pharma marketers, with close to 65% stating it has already been implemented within their marketing stack.

Social Listening Tools; Content Marketing and Optimization; Digital Analytics Tools; Automation (Campaign Optimization); 13%; 10%; 9%; 8%; 46%; 38%; 37%; 29%; 43%; 39%; 38%; 33%; 20%; 16%; 11%; 10%; Not Implemented; Implementing; Actively Using; Advanced

Primary Research

Channel Preference – Marketer vs HCP

Channel Preference // Marketer vs HCP

Key Takeaways:

Top 3 channels preferred by HCPs: Online journals, websites, and KOL webinars

Top 3 channels preferred by pharma marketers: KOL webinars, social apps, and e-Detailing

  • Spend vs ROI – Greatest return: KOL webinars

  • Spend vs ROI – Least return: Social apps

  • Spend vs ROI – Balanced return: Marketing emails

Pharma marketers must focus on improving the availability of their content in journals and websites

HIGH; HCP preference; Low; Online journals; Websites; KOL webinars; e-Detailing; Marketing emails; Rep emails; Social apps; Remote detailing; Text messaging; Low; HIGH; Pharma marketer preference

HCP Preference source - The Digital Savvy HCP Survey 2019

About Indegene

Indegene helps global healthcare organizations address complex challenges by seamlessly integrating analytics, technology, operations, and medical expertise. We help clients drive outcomes, revenue, and productivity improvements by making giant leaps in digital transformation, customer engagement, health reforms, healthcare cost reduction, and health outcomes improvement.

With offices in the US, Canada, UK, China, India, and Australia, Indegene can partner globally with clients; leverage a global talent pool of clinicians, technologists, domain experts, and business process specialists; deploy global infrastructure and proprietary IP assets; and harness global healthcare knowledge to solve complex industry challenges. Indegene works with over 100 global customers, including pharmaceutical and biotech companies, medical device manufacturers, life sciences organizations, health plans, health systems, ACOs, and provider organizations.

Download↗Talk to us

From Promise To Performance.

Trusted by all 20 of the world's top 20 pharmaceutical companies, Indegene helps life sciences organizations accelerate outcomes across the entire value chain.